CN103957893B - 新的经涂布控释活性剂载体 - Google Patents

新的经涂布控释活性剂载体 Download PDF

Info

Publication number
CN103957893B
CN103957893B CN201280055056.6A CN201280055056A CN103957893B CN 103957893 B CN103957893 B CN 103957893B CN 201280055056 A CN201280055056 A CN 201280055056A CN 103957893 B CN103957893 B CN 103957893B
Authority
CN
China
Prior art keywords
calcium carbonate
carrier according
active agent
reacted
natural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201280055056.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN103957893A (zh
Inventor
P·施瓦岑特鲁勃
N·迪马尤塔
J·舍尔科普夫
C·J·里奇韦
P·A·C·甘恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Omya Development AG
Original Assignee
Omya Development AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47143128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN103957893(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP11188597.6A external-priority patent/EP2591772B1/en
Application filed by Omya Development AG filed Critical Omya Development AG
Publication of CN103957893A publication Critical patent/CN103957893A/zh
Application granted granted Critical
Publication of CN103957893B publication Critical patent/CN103957893B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
CN201280055056.6A 2011-11-10 2012-11-08 新的经涂布控释活性剂载体 Active CN103957893B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP11188597.6A EP2591772B1 (en) 2011-11-10 2011-11-10 New coated controlled release active agent carriers
EP11188597.6 2011-11-10
US201161559253P 2011-11-14 2011-11-14
US61/559,253 2011-11-14
PCT/EP2012/072161 WO2013068478A1 (en) 2011-11-10 2012-11-08 New coated controlled release active agent carriers

Publications (2)

Publication Number Publication Date
CN103957893A CN103957893A (zh) 2014-07-30
CN103957893B true CN103957893B (zh) 2017-08-15

Family

ID=47143128

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280055056.6A Active CN103957893B (zh) 2011-11-10 2012-11-08 新的经涂布控释活性剂载体

Country Status (25)

Country Link
US (1) US9579291B2 (https=)
EP (1) EP2747752B1 (https=)
KR (1) KR101612655B1 (https=)
CN (1) CN103957893B (https=)
AU (1) AU2012334082B2 (https=)
BR (1) BR112014011310B1 (https=)
CA (1) CA2851069C (https=)
CL (1) CL2014001172A1 (https=)
CO (1) CO6940430A2 (https=)
DK (1) DK2747752T3 (https=)
ES (1) ES2553091T3 (https=)
IL (1) IL231959A0 (https=)
IN (1) IN2014MN00843A (https=)
MX (1) MX346884B (https=)
MY (1) MY168425A (https=)
PH (1) PH12014500750A1 (https=)
PL (1) PL2747752T3 (https=)
PT (1) PT2747752E (https=)
RU (2) RU2018123688A (https=)
SG (1) SG11201401350WA (https=)
SI (1) SI2747752T1 (https=)
SM (1) SMT201600010B (https=)
TW (1) TWI625129B (https=)
WO (1) WO2013068478A1 (https=)
ZA (1) ZA201403611B (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2536836T3 (es) 2012-10-12 2015-05-29 Omya International Ag Formulación de medicamento gastrorretentivo y sistemas de liberación y su método de preparación usando carbonato de calcio transformado en funcional
JP2016514095A (ja) * 2013-02-15 2016-05-19 ウェルマーク インターナショナルＷｅｌｌｍａｒｋ Ｉｎｔｅｒｎａｔｉｏｎａｌ 無機飼料を介する製剤
TR201815327T4 (tr) * 2015-06-10 2018-11-21 Omya Int Ag Anti-blokaj maddesi olarak yüzeyi tepkimeye girmiş kalsiyum karbonat kullanımı.
EP3176222A1 (en) * 2015-12-01 2017-06-07 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
EP3426706A1 (en) 2016-03-08 2019-01-16 Living Proof, Inc. Long lasting cosmetic compositions
EP3275947A1 (en) * 2016-07-25 2018-01-31 Omya International AG Surface-reacted calcium carbonate with functional cations
EP3400810A1 (en) * 2017-05-11 2018-11-14 Omya International AG Surface-reacted calcium carbonate in food
CN107258776A (zh) * 2017-06-29 2017-10-20 山东大农药业有限公司 一种缓释农药颗粒剂及其制备方法
CA3074845A1 (en) 2017-09-13 2019-03-21 Living Proof, Inc. Color protectant compositions
EP3681920B1 (en) 2017-09-13 2025-06-25 Living Proof, Inc. Long lasting cosmetic compositions
US11510877B2 (en) 2017-10-10 2022-11-29 Capsugel Belgium Nv Gelling multiparticulates
AU2018370210B2 (en) 2017-11-20 2024-09-26 Living Proof, Inc. Properties for achieving long-lasting cosmetic performance
EP3520798A1 (en) * 2018-01-31 2019-08-07 Omya International AG Use of functionalized calcium carbonate as active ingredient
EP3784711A1 (en) 2018-04-27 2021-03-03 Living Proof, Inc. Long lasting cosmetic compositions
EP3598105A1 (en) 2018-07-20 2020-01-22 Omya International AG Method for detecting phosphate and/or sulphate salts on the surface of a substrate or within a substrate, use of a lwir detecting device and a lwir imaging system
WO2020091456A1 (ko) * 2018-10-31 2020-05-07 ㈜아모레퍼시픽 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물
KR102739456B1 (ko) * 2018-10-31 2024-12-09 (주)아모레퍼시픽 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물
US20220105047A1 (en) * 2019-01-16 2022-04-07 Research Cooperation Foundation Of Yeungnam University Microcapsule composition using alginate gel, and method for producing same
KR102936013B1 (ko) 2019-12-03 2026-03-10 (주)아모레퍼시픽 바이오 폴리머를 포함하는 효능물질 전달체
CN111436426B (zh) * 2020-05-11 2022-04-08 北京首创股份有限公司 供水管道输水用二次加氯胶囊及其制备方法
EP3928859A1 (en) * 2020-06-23 2021-12-29 Omya International AG Surface-reacted calcium carbonate in a process for the production of a loaded microcapsule
AR123009A1 (es) 2020-07-20 2022-10-19 Omya Int Ag Agente estabilizante para composición probiótica
WO2025132417A1 (en) 2023-12-19 2025-06-26 Omya International Ag Granular material comprising a carboxymethylcellulose binder
WO2025207519A1 (en) * 2024-03-23 2025-10-02 Texas Tech University System Biocompatible and biodegradable polymer nanodiscs as lipoprotein-mimicking nanocarriers with high stability and long circulation time for drug delivery

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
CN102170867A (zh) * 2008-09-30 2011-08-31 Omya发展股份公司 新的受控释放的活性剂载体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2223896A1 (de) 1972-05-17 1973-11-29 Sanol Arznei Schwarz Gmbh Verfahren zum ueberziehen von feinteiligen arzneimitteln
US4657784A (en) 1986-03-10 1987-04-14 Ecolab Inc. Process for encapsulating particles with at least two coating layers having different melting points
ATE180668T1 (de) * 1992-12-01 1999-06-15 Spirig Ag S(+)-ibuprofen enthaltende arzneimittel
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
EP1891937A1 (en) 2006-08-25 2008-02-27 Novartis AG Galenic formulations of aliskiren
ES2342495T3 (es) * 2007-03-21 2010-07-07 Omya Development Ag Procedimiento de eliminacion de compuestos disruptores endocrinos.
ATE480597T1 (de) 2007-12-12 2010-09-15 Omya Development Ag Verfahren zur herstellung von oberflächenreaktives fällungskalziumkarbonat
EP2421507B1 (en) 2009-04-24 2019-01-23 Fertin Pharma A/S Chewing gum and particulate material for controlled release of active ingredients
EP2264108B1 (en) 2009-06-15 2012-02-15 Omya Development AG Process to prepare a surface-reacted calcium carbonate implementing a weak acid
PT2264109E (pt) 2009-06-15 2012-05-09 Omya Development Ag Processo de preparação de carbonato de cálcio com superfície tratada por reacção e sua utilização

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
CN102170867A (zh) * 2008-09-30 2011-08-31 Omya发展股份公司 新的受控释放的活性剂载体

Also Published As

Publication number Publication date
BR112014011310A2 (pt) 2017-05-09
EP2747752A1 (en) 2014-07-02
CA2851069A1 (en) 2013-05-16
RU2665382C1 (ru) 2018-08-29
CN103957893A (zh) 2014-07-30
MY168425A (en) 2018-11-09
RU2018123688A3 (https=) 2022-01-24
NZ623515A (en) 2016-09-30
CO6940430A2 (es) 2014-05-09
KR101612655B1 (ko) 2016-04-14
MX2014005466A (es) 2014-08-22
ES2553091T3 (es) 2015-12-04
BR112014011310B1 (pt) 2022-04-12
CL2014001172A1 (es) 2014-09-12
KR20140091054A (ko) 2014-07-18
PL2747752T3 (pl) 2016-04-29
WO2013068478A1 (en) 2013-05-16
US9579291B2 (en) 2017-02-28
TW201328709A (zh) 2013-07-16
ZA201403611B (en) 2015-07-29
RU2018123688A (ru) 2019-03-07
IN2014MN00843A (https=) 2015-07-03
SG11201401350WA (en) 2014-05-29
IL231959A0 (en) 2014-05-28
SI2747752T1 (sl) 2015-12-31
SMT201600010B (it) 2016-02-25
DK2747752T3 (en) 2016-01-18
AU2012334082A1 (en) 2014-04-24
AU2012334082B2 (en) 2015-10-29
TWI625129B (zh) 2018-06-01
CA2851069C (en) 2016-05-31
MX346884B (es) 2017-04-05
PH12014500750A1 (en) 2014-05-12
EP2747752B1 (en) 2015-10-07
PT2747752E (pt) 2016-02-08
US20140248340A1 (en) 2014-09-04

Similar Documents

Publication Publication Date Title
CN103957893B (zh) 新的经涂布控释活性剂载体
EP2591772B1 (en) New coated controlled release active agent carriers
CN102170867B (zh) 新的受控释放的活性剂载体
AU2015265924B2 (en) Method for the production of granules comprising surface-reacted calcium carbonate
Rattes et al. Spray drying conditions and encapsulating composition effects on formation and properties of sodium diclofenac microparticles
JP2018537565A (ja) 表面反応炭酸カルシウムを含む細粒の製造方法
JP5215178B2 (ja) 短時間加熱および急速乾燥による低溶解性活性物質をベースとする固溶体の生成法
Ibrahim Formulation and evaluation of mefenamic acid sustained release matrix pellets
EP2957603A1 (en) Method for the production of granules comprising surface-reacted calcium carbonate
EP2949708B1 (en) Method for the production of granules comprising surface-reacted calcium carbonate
NZ623515B2 (en) New coated controlled release active agent carriers
CN115380006A (zh) 用于生产自由流动粒状物的方法
WO2017209216A1 (ja) 難溶性薬物の微粒子を含有する医薬組成物の製造方法
EP3860572A1 (en) Spherical beads for use in producing pharmaceutically active pellets
IES20110379A2 (en) A process for producing a tablet

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant